Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography. | World J Clin Cases | 2023 | 38130793 | PubTator, text mining | PubMed |
| Surveillance for hepatocellular carcinoma in non-alcoholic fatty liver disease patients: towards personalized risk stratification. | Hepatobiliary Surg Nutr | 2023 | 38115941 | PubTator, text mining | PubMed |
| Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future. | Hepatobiliary Surg Nutr | 2023 | 38115940 | PubTator, text mining | PubMed |
| Up-to-date global epidemiology of nonalcoholic fatty liver disease. | Hepatobiliary Surg Nutr | 2023 | 38115930 | PubTator, text mining | PubMed |
| Refining the diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis. | Commun Med (Lond) | 2023 | 38110524 | PubTator, text mining | PubMed |
| Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic. | Front Med (Lausanne) | 2023 | 38089874 | PubTator, text mining | PubMed |
| miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD. | Open Med (Wars) | 2023 | 38075030 | PubTator, text mining | PubMed |
| Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area †. | Int J Mol Sci | 2023 | 38068980 | PubTator, text mining | PubMed |
| Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity. | Nutrients | 2023 | 38068856 | PubTator, text mining | PubMed |
| Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study. | J Clin Med | 2023 | 38068330 | PubTator, text mining | PubMed |
| The diagnostic yield of exome sequencing in liver diseases from a curated gene panel. | Sci Rep | 2023 | 38057357 | PubTator, text mining | PubMed |
| Beethoven, Infected with Hepatitis B, Inspired the "Beethoven Virus." | Mol Cells | 2023 | 38052489 | PubTator, text mining | PubMed |
| Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). | J Obes Metab Syndr | 2023 | 38049180 | PubTator, text mining | PubMed |
| Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease. | Front Endocrinol (Lausanne) | 2023 | 38034020 | PubTator, text mining | PubMed |
| Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations. | Diabetes Metab Syndr Obes | 2023 | 38028995 | PubTator, text mining | PubMed |
| Molecular genetics of neuropsychiatric illness: some musings. | Front Genet | 2023 | 38028602 | PubTator, text mining | PubMed |
| High-frequency variants in PKA signaling-related genes within a large pediatric cohort with obesity or metabolic abnormalities. | Front Endocrinol (Lausanne) | 2023 | 38027204 | PubTator, text mining | PubMed |
| Editorial: Interaction of endocrine disorders and metabolic associated fatty liver disease: the genetic and epigenetic basis. | Front Endocrinol (Lausanne) | 2023 | 38027111 | PubTator, text mining | PubMed |
| Prospective therapeutics for intestinal and hepatic fibrosis. | Bioeng Transl Med | 2023 | 38023697 | PubTator, text mining | PubMed |
| Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD). | EXCLI J | 2023 | 38023570 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=26